British Columbia Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5M Sell
63,996
-51,945
-45% -$28.2M 0.19% 99
2025
Q4
$67.2M Sell
115,941
-51,572
-31% -$29.2M 0.35% 51
2025
Q3
$81.2M Buy
167,513
+35,042
+26% +$16.3M 0.47% 40
2025
Q2
$53.7M Sell
132,471
-37,958
-22% -$15.9M 0.31% 72
2025
Q1
$84.8M Sell
170,429
-32,972
-16% -$17.9M 0.52% 35
2024
Q4
$106M Buy
203,401
+61,710
+44% +$33.9M 0.63% 27
2024
Q3
$87.6M Sell
141,691
-12,421
-8% -$7.35M 0.53% 33
2024
Q2
$85.2M Buy
154,112
+65,036
+73% +$37.3M 0.51% 32
2024
Q1
$51.8M Buy
89,076
+44,648
+100% +$25.1M 0.36% 61
2023
Q4
$23.6M Buy
44,428
+9,320
+27% +$4.51M 0.19% 107
2023
Q3
$17.8M Sell
35,108
-28,489
-45% -$15.2M 0.17% 104
2023
Q2
$33.2M Sell
63,597
-43,119
-40% -$23.3M 0.31% 73
2023
Q1
$61.5M Buy
106,716
+3,951
+4% +$2.23M 0.64% 39
2022
Q4
$56.6M Sell
102,765
-4,023
-4% -$2.13M 0.62% 39
2022
Q3
$54.2M Buy
106,788
+16,480
+18% +$9.22M 0.61% 35
2022
Q2
$49.1M Buy
90,308
+29,378
+48% +$16.2M 0.47% 47
2022
Q1
$36M Sell
60,930
-8,252
-12% -$4.74M 0.23% 80
2021
Q4
$46.2M Sell
69,182
-3,499
-5% -$2.18M 0.26% 70
2021
Q3
$41.5M Sell
72,681
-230
-0.3% -$126K 0.24% 72
2021
Q2
$36.8M Buy
72,911
+7,856
+12% +$3.71M 0.23% 86
2021
Q1
$29.7M Sell
65,055
-1,884
-3% -$899K 0.21% 87
2020
Q4
$31.2M Sell
66,939
-1,662
-2% -$779K 0.22% 95
2020
Q3
$30.3M Buy
68,601
+4,640
+7% +$1.92M 0.25% 88
2020
Q2
$23.2M Buy
63,961
+20,113
+46% +$6.74M 0.23% 93
2020
Q1
$12.4M Sell
43,848
-50,653
-54% -$16M 0.21% 95
2019
Q4
$30.7M Sell
94,501
-2,106
-2% -$639K 0.23% 100
2019
Q3
$28.1M Buy
96,607
+4,631
+5% +$1.33M 0.27% 91
2019
Q2
$27M Buy
91,976
+1,967
+2% +$542K 0.24% 102
2019
Q1
$24.6M Sell
90,009
-42,891
-32% -$10.7M 0.22% 111
2018
Q4
$29.7M Sell
132,900
-164
-0.1% -$38.5K 0.27% 93
2018
Q3
$32.5M Sell
133,064
-16,105
-11% -$3.7M 0.34% 68
2018
Q2
$30.9M Sell
149,169
-3,196
-2% -$678K 0.27% 82
2018
Q1
$31.5M Sell
152,365
-23,771
-13% -$4.99M 0.24% 100
2017
Q4
$33.4M Buy
176,136
+13,347
+8% +$2.56M 0.24% 100
2017
Q3
$30.8M Sell
162,789
-1,616
-1% -$293K 0.24% 100
2017
Q2
$28.7M Sell
164,405
-67,886
-29% -$11.4M 0.23% 106
2017
Q1
$35.7M Sell
232,291
-22,747
-9% -$3.48M 0.28% 73
2016
Q4
$36M Buy
255,038
+25,326
+11% +$3.73M 0.32% 73
2016
Q3
$36.5M Sell
229,712
-34,222
-13% -$5.27M 0.37% 62
2016
Q2
$39M Buy
263,934
+8,525
+3% +$1.26M 0.34% 64
2016
Q1
$36.2M Sell
255,409
-23,771
-9% -$3.19M 0.34% 66
2015
Q4
$39.6M Buy
279,180
+8,377
+3% +$1.12M 0.38% 59
2015
Q3
$33.1M Buy
270,803
+3,933
+1% +$512K 0.34% 70
2015
Q2
$34.6M Buy
266,870
+7,228
+3% +$942K 0.33% 69
2015
Q1
$34.9M Sell
259,642
-34,293
-12% -$4.42M 0.31% 75
2014
Q4
$36.8M Sell
293,935
-18,129
-6% -$2.2M 0.3% 82
2014
Q3
$38M Sell
312,064
-5,630
-2% -$685K 0.32% 75
2014
Q2
$37.5M Buy
317,694
+3,626
+1% +$427K 0.3% 83
2014
Q1
$37.8M Sell
314,068
-10,789
-3% -$1.28M 0.32% 78
2013
Q4
$36.2M Sell
324,857
-36,046
-10% -$3.58M 0.29% 88
2013
Q3
$33.3M Buy
360,903
+18,329
+5% +$1.66M 0.28% 90
2013
Q2
$29M Buy
+342,574
New +$28.5M 0.24% 104

Other funds holding TMO

British Columbia Investment Management's TMO Position: Q1 2026 in Review

British Columbia Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 45% in Q1 2026, selling an estimated $28.2M and leaving 63,996 shares worth $31.5M. The position accounts for 0.19% of the portfolio, ranked #99.

British Columbia Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $106M in Q4 2024. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • British Columbia Investment Management held 63,996 shares of Thermo Fisher Scientific worth $31.5M as of Q1 2026.
  • British Columbia Investment Management sold 51,945 Thermo Fisher Scientific shares in Q1 2026, an estimated $28.2M.
  • Thermo Fisher Scientific made up 0.19% of British Columbia Investment Management's portfolio in Q1 2026, its #99 holding.
  • British Columbia Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Thermo Fisher Scientific position peaked at $106M in Q4 2024.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.